Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 11, 2004
- IFPW General Membership Meeting
October 11, 2004
- In-house Product Launchings Expected from FY2008: Nippon Kayaku
October 11, 2004
- NHI Pricing Should Be Based on Market Price Principle: Prof. Tsutsumi
October 11, 2004
- Pharmacoeconomic Evaluation of Long-term Effects on Health Recommended
October 11, 2004
- BUSINESS NEWS IN BRIEF
October 11, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
October 11, 2004
- Annual Business Results
October 11, 2004
- OTC NEWS IN BRIEF
October 11, 2004
- 1st Qtr Business Results
October 11, 2004
- MEDICAL DEVICE NEWS IN BRIEF
October 11, 2004
- Business Forecast
October 11, 2004
- DIAGNOSTIC NEWS IN BRIEF
October 11, 2004
- ZLB Behring to Expand Plasma Fraction Business in Japan: Mr Strenger
October 4, 2004
- OTC NEWS IN BRIEF
October 4, 2004
- Itochu Sees Contract Drug Distribution as Growth Opportunity
October 4, 2004
- Olympus to Beef Up Biomaterials, Tissue Engineering Business
October 4, 2004
- MediciNova to Step Forward in Global Drug Development, Commercialization
October 4, 2004
- Iryo Proverbs Reveal Japanese Spirit (23)
October 4, 2004
- Booklet on MRs' Roles to Be Thoroughly Revised
October 4, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…